Cargando…
A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
BACKGROUND: Ample evidence indicates the efficacy of serotonin type 3 (5-HT(3)) receptor antagonists in the treatment of patients with diarrhea-predominant irritable bowel syndrome (IBS-D). Mirtazapine is an atypical antidepressant with a well-known 5-HT(3) receptor antagonist property. This study,...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860197/ https://www.ncbi.nlm.nih.gov/pubmed/33536043 http://dx.doi.org/10.1186/s13030-021-00205-2 |